DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Biocon Limited — Monitoring Agency Report

NSE 1 hr ago·5 Aug 2026, 11:38 am

Biocon

Biocon Limited has released its monitoring agency report for the quarter ended June 30, 2026. This document provides an independent assessment of the company's financial health and operational performance during the specified period.

For investors, this report offers a transparent view of Biocon's current standing. It helps validate the company's reported figures and can provide early insights into any emerging trends or risks within its business segments.

Investors should closely review the agency's commentary on Biocon's liquidity, debt levels, and overall operational efficiency. This information is crucial for assessing the company's stability and future growth potential.